Andrea E Dunaif, MD
img_Andrea E Dunaif
PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Are you a patient?
Endocrine, Diabetes and Bone Diseases (Endocrinology), Internal Medicine

MD, Columbia University College of Physicians & Surgeons

Residency, Internal Medicine, New York Presbyterian Hospital-Weill Cornell

Fellowship, Endocrinology, Diabetes and Metabolism, Massachusetts General Hospital


Diabetes & Metabolism
American Board of Internal Medicine
Andrea Dunaif, MD
From the Ovary to the Pancreas: Insulin, Androgens & Cardiometabolic Risk in Women

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Dunaif during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Novo Nordisk
  • Fractyl Laboratories, Inc
  • Equator Therapuetics

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose

  • New Jersey Association of Endocrinologists
  • Metabolic Endocrine Foundation
  • Institute of Medical and Nursing Education

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • National Institutes of Health (NIH)
  • SLACK Incorporated

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.